You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MET inhibition

Showing 1 - 25 of 4,702
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mechanical Neck Pain Trial in Karachi (Autogenic Inhibition MET, Reciprocal Inhibition MET)

Completed
  • Mechanical Neck Pain
  • Autogenic Inhibition MET
  • Reciprocal Inhibition MET
  • Karachi, Sindh, Pakistan
    Sindh Institue of Physical Medicine and Rehabilitation
Feb 2, 2022

Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Oxford, United Kingdom
    Oxford University Hospital NHS Trust
Jun 14, 2021

Malignant Tumor of Esophagus, Malignant Tumor of Stomach Trial in Villejuif (Oxaliplatin, Folinic Acid, 5-fluoro-uracil)

Completed
  • Malignant Neoplasm of Esophagus
  • Malignant Neoplasm of Stomach
  • Villejuif, France
    Institut Gustave Roussy
Nov 13, 2020

NSCLC Trial in United States (capmatinib)

Recruiting
  • Non-small Cell Lung Cancer
  • La Jolla, California
  • +7 more
Oct 5, 2022

Neck Pain Trial in Lahore (autogenic inhibition, reciprocal inhibition)

Recruiting
  • Neck Pain
  • autogenic inhibition
  • reciprocal inhibition
  • Lahore, Punjab, Pakistan
    Nusrat Rashid Medical Complex
Oct 11, 2023

Non Specific Neck Pain Trial in Cairo (graston and muscle energy technique)

Completed
  • Non Specific Neck Pain
  • graston and muscle energy technique
  • Cairo, Egypt
    Helwan University
Dec 8, 2022

Chronic Non Specific Low Back Pain Trial (Experimental: Group A: integrated neuromuscular inhibition technique, Experimental:

Not yet recruiting
  • Chronic Non Specific Low Back Pain
  • Experimental: Group A: integrated neuromuscular inhibition technique
  • +2 more
  • (no location specified)
Oct 30, 2023

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 10, 2023

NSCLC Trial in Worldwide (Capmatinib, Amivantamab)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Orange, California
  • +40 more
Aug 3, 2022

Advanced NSCLC With MET Mutations Trial in United States (Tepotinib)

Recruiting
  • Advanced Non-Small Cell Lung Cancer With MET Mutations
  • Aurora, Colorado
  • +3 more
Jun 27, 2022

Advanced Cancer, Non Small Cell Lung Cancer Trial (Tepotinib, Pembrolizumab)

Not yet recruiting
  • Advanced Cancer
  • Non Small Cell Lung Cancer
  • (no location specified)
Mar 28, 2023

Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)

Not yet recruiting
  • Lactation Suppressed
  • Cabergoline 1 MG
  • Placebo
  • Stanford, California
    Stanford University
Sep 1, 2023

Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

Recruiting
  • Urothelial Cancer
  • Niraparib plus Cabozantinib
  • Barcelona, Cataluña, Spain
  • +10 more
Feb 8, 2022

Piriformis Syndrome Trial in Gojra (Fascial distortion method with neuromuscular inhibition technique, Fascial distortion

Not yet recruiting
  • Piriformis Syndrome
  • Fascial distortion method with neuromuscular inhibition technique
  • Fascial distortion method
  • Gojra, Punjab, Pakistan
    GOVT Eye Cum General Hospital Gojra (THQ)
May 31, 2022

Posterior Capsule Opacification Trial in Holon (CleaRing)

Recruiting
  • Posterior Capsule Opacification
  • CleaRing
  • Holon, Tel Aviv, Israel
    Wolfson Medical Center
Oct 11, 2023

Melanoma Trial in Worldwide (Ceralasertib, Durvalumab)

Recruiting
  • Melanoma
  • Los Angeles, California
  • +75 more
Dec 5, 2022

ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

Terminated
Has Results
  • ALK Fusion Protein Expression
  • +14 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2020

NSCLC Trial in Worldwide (Osimertinib + Savolitinib, Savolitinib + Placebo)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Osimertinib + Savolitinib
  • Savolitinib + Placebo
  • Duarte, California
  • +20 more
Dec 2, 2022

Sacroiliac Joint Somatic Dysfunction Trial in Giza (Strain-Counterstrain, Muscle Energy Technique)

Completed
  • Sacroiliac Joint Somatic Dysfunction
  • Strain-Counterstrain
  • Muscle Energy Technique
  • Giza, Egypt
    Warraq Central hospital
Mar 7, 2022

Knee Osteoarthritis Trial in Lahore (Graston technique, muscle energy technique)

Not yet recruiting
  • Knee Osteoarthritis
  • Graston technique
  • muscle energy technique
  • Lahore, Punjab, Pakistan
    Chaudary Muhammad Akram Teaching Hospital
May 11, 2022

Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated

Not yet recruiting
  • Immunization; Infection
  • +2 more
  • Standard Dose Quadrivalent Inactivated Influenza Vaccine
  • High Dose Quadrivalent Inactivated Influenza Vaccine
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jul 11, 2023

H3N2 Influenza Trial in United States (Placebo, Sing2016 M2SR H3N2)

Recruiting
  • H3N2 Influenza
  • Placebo
  • Sing2016 M2SR H3N2
  • Iowa City, Iowa
  • +3 more
Mar 10, 2022

Recurrent Endometrial Cancer, Solid Tumors Trial in Pittsburgh (pembrolizumab, Sitravatinib)

Recruiting
  • Recurrent Endometrial Cancer
  • Solid Tumors
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 12, 2022

Tumors Trial (ABN401)

Not yet recruiting
  • Neoplasms
  • (no location specified)
May 21, 2023

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

Completed
Has Results
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC V7
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021